March 13 (Reuters) - Cesca Therapeutics Inc-
* Cesca Therapeutics announces closing of $5 million revolving line of credit
* Has set-up a wholly-owned subsidiary, Thermogenesis Corp, to separately own and operate its device business
* Clinical development activities will remain with cesca, parent company
* “Our goal is to make thermogenesis cash-flow neutral within next 12 months” Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.